Vaccination after VITT Forty persons in whom thrombosis and thrombocytopenia had developed after an initial ChAdOx1 nCoV-19 vaccination were given a second dose of a Covid-19 vaccine, most commonly BNT162b2. None of the patients had a recurrence of thrombosis and thrombocytopenia.
|Number of pages||1|
|Journal||New England Journal of Medicine|
|Publication status||Published - 22 Dec 2021|
Bibliographical noteFunding Information: No funding information.
Open Access: Free to read, but no Open Access licence. For personal use only. No other uses without permission.
Publisher Copyright: Copyright © 2022 Massachusetts Medical Society. All rights reserved.
Citation: Lacy, Joanne, Sue Pavord, and Kevin E. Brown. "VITT and Second Doses of Covid-19 Vaccine." New England Journal of Medicine 386.1 (2022): 95-95.